590 related articles for article (PubMed ID: 20121166)
1. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
2. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
4. Serum and urinary metabonomic study of human osteosarcoma.
Zhang Z; Qiu Y; Hua Y; Wang Y; Chen T; Zhao A; Chi Y; Pan L; Hu S; Li J; Yang C; Li G; Sun W; Cai Z; Jia W
J Proteome Res; 2010 Sep; 9(9):4861-8. PubMed ID: 20690664
[TBL] [Abstract][Full Text] [Related]
5. [Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography-mass spectrometry].
Ma YL; Liu WJ; Peng JY; Zhang P; Chen HQ; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):386-90. PubMed ID: 19598026
[TBL] [Abstract][Full Text] [Related]
6. [Effect of jinfu kang to experimental precancerous colon lesions and urinary metabolites in rat].
Qiu YP; Su MM; Wu DZ; Zhao AH; Liu YM; Jia W
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2653-7. PubMed ID: 19216165
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
Qiu Y; Cai G; Su M; Chen T; Zheng X; Xu Y; Ni Y; Zhao A; Xu LX; Cai S; Jia W
J Proteome Res; 2009 Oct; 8(10):4844-50. PubMed ID: 19678709
[TBL] [Abstract][Full Text] [Related]
8. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints.
Teul J; Rupérez FJ; Garcia A; Vaysse J; Balayssac S; Gilard V; Malet-Martino M; Martin-Ventura JL; Blanco-Colio LM; Tuñón J; Egido J; Barbas C
J Proteome Res; 2009 Dec; 8(12):5580-9. PubMed ID: 19813770
[TBL] [Abstract][Full Text] [Related]
9. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
Chang KL; New LS; Mal M; Goh CW; Aw CC; Browne ER; Chan EC
J Proteome Res; 2011 Apr; 10(4):2079-87. PubMed ID: 21355552
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive urinary metabonomic diagnosis of human bladder cancer.
Pasikanti KK; Esuvaranathan K; Ho PC; Mahendran R; Kamaraj R; Wu QH; Chiong E; Chan EC
J Proteome Res; 2010 Jun; 9(6):2988-95. PubMed ID: 20337499
[TBL] [Abstract][Full Text] [Related]
12. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis.
Li ZF; Wang J; Huang C; Zhang S; Yang J; Jiang A; Zhou R; Pan D
Rapid Commun Mass Spectrom; 2010 Sep; 24(18):2765-75. PubMed ID: 20814984
[TBL] [Abstract][Full Text] [Related]
13. Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery.
Sieber M; Wagner S; Rached E; Amberg A; Mally A; Dekant W
Chem Res Toxicol; 2009 Jul; 22(7):1221-31. PubMed ID: 19610676
[TBL] [Abstract][Full Text] [Related]
14. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
15. Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats.
Liang X; Chen X; Liang Q; Zhang H; Hu P; Wang Y; Luo G
J Proteome Res; 2011 Feb; 10(2):790-9. PubMed ID: 21090666
[TBL] [Abstract][Full Text] [Related]
16. Metabonomic profiling of diet-induced hyperlipidaemia in a rat model.
Zhang Q; Wang G; A J; Ma B; Dua Y; Zhu L; Wu D
Biomarkers; 2010 May; 15(3):205-16. PubMed ID: 20001218
[TBL] [Abstract][Full Text] [Related]
17. Metabonomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry.
Zhang F; Jia Z; Gao P; Kong H; Li X; Lu X; Wu Y; Xu G
Mol Biosyst; 2010 May; 6(5):852-61. PubMed ID: 20567771
[TBL] [Abstract][Full Text] [Related]
18. Urinary metabonomics study in a rat model in response to protein-energy malnutrition by using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.
Wu Z; Li M; Zhao C; Zhou J; Chang Y; Li X; Gao P; Lu X; Li Y; Xu G
Mol Biosyst; 2010 Nov; 6(11):2157-63. PubMed ID: 20717558
[TBL] [Abstract][Full Text] [Related]
19. Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment.
Liao W; Wei H; Wang X; Qiu Y; Gou X; Zhang X; Zhou M; Wu J; Wu T; Kou F; Zhang Y; Bian Z; Xie G; Jia W
J Proteome Res; 2012 Jun; 11(6):3436-48. PubMed ID: 22519469
[TBL] [Abstract][Full Text] [Related]
20. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration.
Bu Q; Yan G; Deng P; Peng F; Lin H; Xu Y; Cao Z; Zhou T; Xue A; Wang Y; Cen X; Zhao YL
Nanotechnology; 2010 Mar; 21(12):125105. PubMed ID: 20203358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
